Diagnostic Performance of 18F|DCFPyL|PET/CT in Men with ...

Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men ... - PubMed

18 F-DCFPyL-PET/CT achieved the study's primary endpoint, demonstrating disease localization in the setting of negative standard imaging.

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with ...

CONDOR was a prospective study designed to determine the performance of 18 F-DCFPyL-PET/CT in patients with BCR and uninformative standard imaging.

Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men with ...

A total of 208 men with a median baseline PSA of 0.8 ng/mL (range: 0.2–98.4 ng/mL) underwent 18F-DCFPyL-PET/CT. The CLR was 84.8%–87.0% (lower bound of 95% CI: ...

18 F-DCFPyL PET/CT in Men with Prostate Cancer - RSNA Journals

Sites of prostate cancer are readily detected with PSMA PET when the disease is occult at CT and 99mTc-MDP bone scanning. This is particularly ...

The diagnostic performance of 18 F-DCFPyL PET in patients with ...

Results: A total of five studies with 258 patients were included, and the pooled sensitivity and specificity of 18F-DCFPyL PSMA PET for primary prostate cancer ...

A phase III, multicenter study to assess the diagnostic performance ...

A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer ...

Diagnostic Performance of PSMA-Targeted 18 F-DCFPyL PET/CT in ...

Results: 208 men with a median baseline PSA of 0.8 ng/mL (range: 0.2 - 98.4 ng/mL) underwent 18F-DCFPyL PET/CT. A total of 59% to 66% of ...

Diagnostic performance of 18 F‑DCFPyL PET vs. 68 Ga‑PSMA PET ...

The pooled sensitivity for 18F-DCFPyL PET was 0.92, while that for 68Ga-PSMA PET/CT was 0.96. These findings have the potential to impact the ...

18F-DCFPyL PET/CT for Initially Diagnosed and Biochemically ...

In sample 1, 25 of the 92 men (27%) demonstrated DCFPyL-avid lesions suspicious for distant metastases. Biopsy was performed in 23 of the 25 men ...

A Phase 2/3 Prospective Multicenter Study of the Diagnostic ...

In cohort A, 18F-DCFPyL-PET/CT demonstrated improved diagnostic performance over conventional imaging modalities with comparable sensitivity (∼ ...

Performance of 18F-DCFPyL PET/CT Imaging in Early Detection of ...

Conclusion: The results suggest that 18F-DCFPyL PET/CT has a relatively high detection rate in BRPCa. The results also indicate that imaging ...

18F-DCFPyL PET/CT Imaging in Patients with Suspected ...

CONDOR phase III trial examining the diagnostic performance of 18F-DCFPyL PET/CT in men with biochemically recurrent prostate cancer, ...

Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on ...

Background: Current imaging modalities are inadequate for localizing and characterizing occult disease in men with BCR PCa, particularly in pts ...

Prospective Evaluation of 18F-DCFPyL PET/CT in Biochemically ...

Results: 18F-DCFPyL PET/CT had an overall positivity rate of 85%, which increased with higher prostate-specific antigen (PSA) levels (ng/mL): 50 ...

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with ...

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter ...

Diagnostic Performance and Safety of 18 F-rhPSMA-7.3 Positron ...

Men with prostate cancer recurrence underwent positron emission tomography/CT 50-70 minutes after intravenous administration of 296±20% MBq 18F- ...

The differential diagnostic value of dual-phase 18F-DCFPyL PET/CT ...

Binding of 18F-DCFPyL at prostate cancer (PC) cells increases over time. The dual-phase protocol may be helpful in separating benign lesions ...

Complex implementation factors demonstrated when evaluating cost ...

Our snapshot of this period of time in our catchment demonstrated that PSMA PET/CT imaging was disproportionately accessed by men of European ...

PSMA PET-CT Accurately Detects Prostate Cancer Spread - NCI

For men with localized prostate cancer at high risk of spreading, results from a large clinical trial show an imaging method known as PSMA ...

(PDF) The diagnostic performance of 18F-DCFPyL PET in patients ...

18F-DCFPyL PSMA PET was successful in detecting primary prostate cancer, with an area under the curve (AUC) of 0.92 (95% CI: 0.89–0.94).Conclusions18F-DCFPyL ...